Charles Schwab Investment Management Inc Sutro Biopharma, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 251,995 shares of STRO stock, worth $511,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,995

Previous 251,995 -0.0%

Holding current value

$511,549

Previous $871,000 46.84%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.88 - $5.01 $101,280 - $176,186	35,167 Added 16.22%	251,995 $871,000
Q2 2024 Aug 12, 2024	BUY	$2.92 - $5.33 $163,379 - $298,224	55,952 Added 34.78%	216,828 $635,000
Q2 2023 Aug 09, 2023	BUY	$4.25 - $5.88 $63,478 - $87,823	14,936 Added 10.23%	160,876 $748,000
Q1 2023 May 11, 2023	BUY	$4.48 - $8.45 $8,032 - $15,150	1,793 Added 1.24%	145,940 $674,000
Q4 2022 Feb 13, 2023	BUY	$5.41 - $8.08 $70,016 - $104,571	12,942 Added 9.86%	144,147 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $59,051 - $81,210	11,422 Added 9.54%	131,205 $729,000
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $395 - $1,038	116 Added 0.1%	119,783 $625,000
Q1 2022 May 13, 2022	BUY	$7.78 - $15.31 $78,718 - $154,906	10,118 Added 9.24%	119,667 $984,000
Q4 2021 Feb 11, 2022	BUY	$14.25 - $23.53 $23,883 - $39,436	1,676 Added 1.55%	109,549 $1.63 Million
Q3 2021 Nov 16, 2021	BUY	$16.88 - $22.38 $65,409 - $86,722	3,875 Added 3.73%	107,873 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $407,478 - $538,332	22,600 Added 27.76%	103,998 $1.93 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $226,700 - $307,704	11,173 Added 15.91%	81,398 $1.85 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $44,358 - $104,696	4,366 Added 6.63%	70,225 $1.53 Million
Q3 2020 Nov 13, 2020	BUY	$7.44 - $13.15 $131,152 - $231,808	17,628 Added 36.55%	65,859 $662,000
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $185,626 - $283,310	25,639 Added 113.49%	48,231 $375,000
Q2 2019 Aug 09, 2019	BUY	$9.69 - $12.23 $91,880 - $115,964	9,482 Added 72.33%	22,592 $258,000
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $113,925 - $194,683	13,110 New	13,110 $119,000

Others Institutions Holding STRO

# of Institutions

136

Shares Held

60.9M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $106M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Sutro Biopharma, Inc. Transaction History